Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

NITRIC OXIDE-RELEASING POLYMERS TO TREAT RESTENOSIS AND RELATED DISORDERS

  • Read more about NITRIC OXIDE-RELEASING POLYMERS TO TREAT RESTENOSIS AND RELATED DISORDERS
US Patent 5,650,447
Filed on 1994-03-17

DEVICE FOR MEASURING INCIDENT LIGHT IN A BODY CAVITY

  • Read more about DEVICE FOR MEASURING INCIDENT LIGHT IN A BODY CAVITY
US Patent 5,505,687
Filed on 1995-02-27

SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS

  • Read more about SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS
US Patent 5,714,511
Filed on 1995-07-31

ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) VIRAL ENVELOPE PRO- TEIN AND METHOD OF TESTING FOR AIDS

  • Read more about ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) VIRAL ENVELOPE PRO- TEIN AND METHOD OF TESTING FOR AIDS
US Patent 5,773,210
Filed on 1993-10-06

METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...

  • Read more about METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASE BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN...
US Patent 5,610,185
Filed on 1995-02-17

HTS-1 GENE, A HUMAN TUMOR SUPPRESSOR GENE

  • Read more about HTS-1 GENE, A HUMAN TUMOR SUPPRESSOR GENE
US Patent 5,491,064
Filed on 1995-01-05

USE OF TUMOR NECROSIS FACTOR AS AN ADJUVANT

  • Read more about USE OF TUMOR NECROSIS FACTOR AS AN ADJUVANT
US Application 08/180,392
Filed on 1994-01-12

METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40

  • Read more about METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
US Patent 5,674,492
Filed on 1994-12-21

METHOD FOR DIAGNOSING TUMORS USING MOUSE MONOCLONAL ANTIBODIES

  • Read more about METHOD FOR DIAGNOSING TUMORS USING MOUSE MONOCLONAL ANTIBODIES
US Patent 5,612,032
Filed on 1994-12-22

TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES

  • Read more about TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES
US Application 08/358,657
Filed on 1994-12-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1575
  • Page 1576
  • Page 1577
  • Page 1578
  • Page 1579
  • Page 1580
  • Page 1581
  • Page 1582
  • Page 1583
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health